atorvastatin and semaglutide Statins Together: Safety Guide Wegovy and Atorvastatin Interaction: Safety,

The risk is amplified when combined with semaglutide, necessitating adjustments to medication doses under medical supervision

Participants achieved an average weight loss of approximately 15% of body weight over 68 weeks, with no evidence that concurrent statin use diminished this effect

But the arrival of cheaper generics could be big news for countries where semaglutide usage is not yet mainstream

Always consult with your healthcare provider if you have questions or concerns about the injection process

Novo Nordisk submitted CagriSema for FDA approval, with a decision expected in late 2026

Close glucose monitoring is advisable, particularly for patients on multiple diabetes medications